Skip to main content

E11 vs Z79.4

E11 (Type 2 diabetes mellitus) compared with Z79.4 (Long term (current) use of insulin), from the official CMS tabular data.

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources

Summary

These codes can be reported together, with E11 sequenced before Z79.4 as the tabular note instructs.

Official rule
What is different?

The conditions named, billing status and chapter.E11 is “Type 2 diabetes mellitus”; Z79.4 is “Long term (current) use of insulin”. E11 is a non-billable header; Z79.4 is billable. E11 sits in E00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89); Z79.4 in Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99).

Registry fact

Can these codes be reported together?

Yes, in the order the notes give.E11 is listed before Z79.4; the sequencing answer below quotes the instruction.

Official ruleGuide: Code First vs Use Additional Code vs Code Also

Is one a parent or header code?

One is a header.E11 is a non-billable header, but Z79.4 is not one of its subdivisions.

Registry fact

Are there sequencing instructions?

Yes.E11 first, Z79.4 as an additional code: E11 carries a Use Additional Code instruction covering Z79.4 (“insulin (Z79.4)”).

Official ruleGuide: Code First vs Use Additional Code vs Code Also

Nothing found in 3 other checks; 1 check does not apply
Is there an Excludes1 relationship?

None.Neither entry carries an Excludes1 note that names the other code. E11 carries 8 Excludes1 notes covering other codes; the side-by-side table quotes them.

Official rule

Is there an Excludes2 relationship?

None.Neither entry carries an Excludes2 note that names the other code. Z79.4 carries 5 Excludes2 notes covering other codes; the side-by-side table quotes them.

Official rule

Is one more specific?

Not comparable.The codes sit in different categories; specificity is only comparable within one category.

Are there other coding relationships?

None found.No laterality, encounter-phase, Table of Neoplasms, Table of Drugs and Chemicals, or history-versus-active-disease relationship links these codes.

MedCoder-derived

Official rule: a tabular instructional note or a section of the ICD-10-CM Official Guidelines, quoted as published. Registry fact: the codes’ own published attributes (titles, billable status, position in the hierarchy, code set). MedCoder-derived: a reading MedCoder computes from those facts; it is not itself a rule. How to read the labels

Can these codes be reported together?

Yes — in the order the notes give.

No Excludes1/Excludes2 relationship exists between these codes in the official tabular list. The sequencing instruction below sets which code is listed first on the claim.

Sequencing on the claim

Sequencing

Additional-code relationship

1st
E11
Type 2 diabetes mellitus
→
then
Z79.4
Long term (current) use of insulin

What we found

E11 first, Z79.4 as an additional code

E11 carries a Use Additional Code instruction covering Z79.4: “insulin (Z79.4)”

What to review

Report Z79.4 after E11 when the documentation supports it.

Guide: Code First vs Use Additional Code vs Code Also

Why it matters

A "Use additional code" note means a secondary code should follow this one to fully describe the condition when the documentation supports it.

Source / rule

CMS ICD-10-CM tabular instructional notes

Official guidance behind these answers

  • Section I.B.7 — Multiple coding for a single condition · applies to: Code first / Use additional code

    In addition to the etiology/manifestation convention that requires two codes to fully describe a single condition that affects multiple body systems, there are other single conditions that also require more than one code. “Use additional code” notes are found in the Tabular List at codes that are not part of an etiology/manifestation pair where a secondary code is useful to fully describe a condition. The sequencing rule is the same as the etiology/manifestation pair, “use additional code” indicates that a secondary code should be added, if known. For example, for bacterial infections that are not included in chapter 1, a secondary code from category B95, Streptococcus, Staphylococcus, and Enterococcus, as the cause of diseases classified elsewhere, or B96, Other bacterial agents as the cause of diseases classified elsewhere, may be required to identify the bacterial organism causing the infection. A “use additional code” note will normally be found at the infectious disease code, indicating a need for the organism code to be added as a secondary code. “Code first” notes are also under certain codes that are not specifically manifestation codes but may be due to an underlying cause. When there is a “code first” note and an underlying condition is present, the underlying condition should be sequenced first, if known. […]

    ICD-10-CM Official Guidelines FY2027

  • Section I.A.13 — Etiology/manifestation convention (“code first”, “use additional code” and “in diseases classified elsewhere” notes) · applies to: Etiology/manifestation convention

    Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, “in diseases classified elsewhere.” Codes with this title are a component of the etiology/ manifestation convention. The code title indicates that it is a manifestation code. “In diseases classified elsewhere” codes are never permitted to be used as first listed or principal diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition. See category F02, Dementia in other diseases classified elsewhere, for an example of this convention. There are manifestation codes that do not have “in diseases classified elsewhere” in the title. For such codes, there is a “use additional code” note at the etiology code and a “code first” note at the manifestation code, and the rules for sequencing apply. […]

    ICD-10-CM Official Guidelines FY2027

Quoted from the ICD-10-CM Official Guidelines for Coding and Reporting in effect for the release shown. The tabular notes above are the code-level instruction; these sections are the convention that says how such a note is applied. Source document (CMS PDF) · Release and checksum

Side by side

Similar descriptions do not make codes interchangeable. The documentation and the official instructions decide which code applies.

Official descriptionDiffers
E11

Type 2 diabetes mellitus

Z79.4

Long term (current) use of insulin

StatusDiffers
E11
Non-billable header

A header is not reported on a claim; a code beneath it is.

Report instead: E11.00, E11.01, E11.10, E11.11, E11.21

Z79.4
Billable
Excludes1Differs
E11
  • diabetes mellitus due to underlying condition (E08.-)
  • drug or chemical induced diabetes mellitus (E09.-)
  • gestational diabetes (O24.4-)
  • neonatal diabetes mellitus (P70.2)
  • postpancreatectomy diabetes mellitus (E13.-)
  • postprocedural diabetes mellitus (E13.-)
  • secondary diabetes mellitus NEC (E13.-)
  • type 1 diabetes mellitus (E10.-)
Z79.4

None at this code

Excludes2Differs
E11

None at this code

Z79.4
  • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
  • long term (current) use of oral antidiabetic drugs (Z79.84)
  • long term (current) use of oral hypoglycemic drugs (Z79.84)
  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Use additional codeDiffers
E11
  • code to identify control using:
  • injectable non-insulin antidiabetic drugs (Z79.85)
  • insulin (Z79.4)
  • oral antidiabetic drugs (Z79.84)
  • oral hypoglycemic drugs (Z79.84)
Z79.4

None at this code

Code alsoDiffers
E11

None at this code

Z79.4
  • any therapeutic drug level monitoring (Z51.81)
  • any follow-up examination (Z08-Z09)
CategoryDiffers
E11

Is itself a category

Z79.4

Z79 Long term (current) drug therapy

ChapterDiffers
E11

E00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89)

Z79.4

Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (Z00-Z99)

IncludesDiffers
E11
  • diabetes (mellitus) due to insulin secretory defect
  • diabetes NOS
  • insulin resistant diabetes (mellitus)
Z79.4
  • long term (current) drug use for prophylactic purposes

No Code first and 7th character note at either code.

Notes are the code’s own tabular entry, quoted as published. A note that names the other code is the one the verdict above rests on. In a row that differs, each code’s own notes are listed under it, and the notes every code shares are listed once beneath them.

Derived from the official CMS ICD-10-CM tabular data (FY2027). A coding-rule comparison, not billing advice: payer-specific edits and medical-necessity policy are outside its scope. All data sources